Legal Representation
Attorney
Lawrence K. Nodine
USPTO Deadlines
Next Deadline
1553 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-10-10)
Due Date
October 10, 2029
Grace Period Ends
April 10, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
27 events| Date | Code | Type | Description |
|---|---|---|---|
| Oct 10, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Oct 10, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Jul 25, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Jul 25, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Jul 5, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Jun 20, 2023 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Jun 13, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Jun 13, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Jun 13, 2023 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Jun 9, 2023 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Apr 14, 2023 | CNSL | R | SUSPENSION LETTER WRITTEN |
| Apr 14, 2023 | GNSL | S | LETTER OF SUSPENSION E-MAILED |
| Apr 14, 2023 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Apr 13, 2023 | ALIE | A | ASSIGNED TO LIE |
| Apr 13, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Apr 13, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Jan 18, 2023 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Aug 4, 2022 | CNSI | R | SUSPENSION INQUIRY WRITTEN |
| Aug 4, 2022 | GNSI | S | INQUIRY TO SUSPENSION E-MAILED |
| Aug 4, 2022 | GNS2 | O | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| Jul 8, 2022 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Dec 21, 2021 | CNSL | R | SUSPENSION LETTER WRITTEN |
| Dec 21, 2021 | GNSL | F | LETTER OF SUSPENSION E-MAILED |
| Dec 21, 2021 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Dec 17, 2021 | DOCK | D | ASSIGNED TO EXAMINER |
| Sep 10, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Jul 2, 2021 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 042
research and development relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; evaluation relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; consultancy relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; testing relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; research and development of pharmaceutical, biotech and vaccine products; consultancy relating to pharmaceutical, biotech and vaccine sectors; advisory services relating to research and development of pharmaceutical, biotech and vaccine products
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
042